SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Benchman who wrote (1102)4/9/1999 5:44:00 AM
From: SgtPepper  Read Replies (1) of 1837
 
Technically, I'd say they are trying to close the breakaway gap back to the $7 range. But, on fundamentals, FDA approval must be given some value, so I'd say a return to the $7 level is unlikely.

At this time, NASDAQ Level II shows many buyers at 8 1/4 to 8 3/8. Only a few sellers all the way back up to $9. Looks to me like the bottom is in, for now.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News